G1 Therapeutics Appoints Mark Avagliano as Chief Business Officer
Go back to G1 Therapeutics Appoints Mark Avagliano as Chief Business Officer| (NASDAQ: GTHX) | Delayed: 7.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.15 | 52 Week High | $ | |||
| Open | $7.15 | 52 Week Low | $ | |||
| Day High | $7.15 | P/E | N/A | |||
| Day Low | $7.15 | EPS | $ | |||
| Volume | 11,752 | |||||
